Graft vs Host Disease - 26 Studies Found
Completed |
: CC-4047 (Pomalidomide) for Graft vs. Host Disease : Graft vs Host Disease : 2008-10-07 : Drug: CC-4047 Other Name: Pomalidomide |
Completed |
: Intra-Arterial Catheter Directed Therapy for Severe Graft vs. Host Disease (GVHD) : Graft vs Host Disease : 2005-09-04 : Procedure: intra-arterial treatment |
Completed |
: Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease : Graft vs Host Disease : 2006-10-12 :
|
Completed |
: Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD) : Graft vs Host Disease : 2010-05-05 : Genetic: Mesenchymal stromal cells Mesenchymal stromal cells (MSC) intravenous infusion at least two fix |
Completed |
: Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease : Graft vs Host Disease : 2012-11-25 :
|
RECRUITING |
: Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) : Graft vs Host Disease : 2024-05-14 : Pacritinib will be given as 100 mg or 200 mg tablets to be taken orally twice daily (12 hours apart) on days 1-28 of a 28 day cycle.Morning and |